- The pharmaceutical site of Riom La Varenne for 10 years within the SMO Biopôle Clermont-Limagne (IN FRENCH). Voir le communiqué de presse
- Valbiotis announces the last visit of the last patient in the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science. Voir le communiqué de presse
- Approval of the agreement concluded by METabolic EXplorer with its main partners on 23 December 2022 under the conciliation procedure (IN FRENCH). Voir le communiqué de presse
- Inauguration of the new production unit of CARBOGEN AMCIS SAS at Biopôle Clermont-Limagne (Saint-Beauzire, Puy de Dôme) Friday, February 3, 2023 (IN FRENCH). Voir le communiqué de presse
- Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure. Voir le communiqué de presse
- Provision of preparatory documents for the Extraordinary General Assembly (IN FRENCH). Voir le communiqué de presse
